Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
34.10
0.00 (0.00%)
At close: Sep 4, 2026, 4:00 PM EDT
34.18
+0.08 (0.23%)
Pre-market: Sep 8, 2026, 8:15 AM EDT
Amylyx Pharmaceuticals Employees
Amylyx Pharmaceuticals had 136 employees as of December 31, 2025. The number of employees increased by 13 or 10.57% compared to the previous year.
Employees
136
Change (1Y)
13
Growth (1Y)
10.57%
Revenue / Employee
n/a
Profits / Employee
-$1,118,324
Market Cap
4.28B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 136 | 13 | 10.57% |
| Dec 31, 2024 | 123 | -261 | -67.97% |
| Dec 31, 2023 | 384 | 122 | 46.56% |
| Sep 30, 2023 | 374 | 137 | 57.81% |
| Jun 30, 2023 | 338 | 112 | 49.56% |
| Mar 31, 2023 | 296 | 91 | 44.39% |
| Dec 31, 2022 | 262 | 57 | 27.80% |
| Sep 30, 2022 | 237 | 127 | 115.45% |
| Jun 30, 2022 | 226 | 116 | 105.45% |
| Dec 31, 2021 | 205 | 171 | 502.94% |
| Sep 30, 2021 | 110 | 76 | 223.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Amneal Pharmaceuticals | 8,700 |
| Hims & Hers Health | 2,442 |
| HUTCHMED (China) | 1,790 |
| Lantheus Holdings | 1,193 |
| Prestige Consumer Healthcare | 890 |
| Indivior Pharmaceuticals | 838 |
| Supernus Pharmaceuticals | 778 |
| BioCryst Pharmaceuticals | 435 |
AMLX News
- 11 days ago - 20 stocks likely to lose money even if the bull market continues - Market Watch
- 12 days ago - Amylyx price target raised to $57 from $55 at Guggenheim - TheFly
- 19 days ago - Amylyx Pharmaceuticals Announces Pricing of an Upsized $500 Million Underwritten Public Offering of Common Stock - Business Wire
- 20 days ago - Amylyx price target raised to $42 from $30 at Mizuho - TheFly
- 20 days ago - Amylyx price target raised to $55 from $40 at Guggenheim - TheFly
- 20 days ago - Amylyx price target raised to $52 from $28 at Baird - TheFly
- 20 days ago - Amylyx price target raised to $39 from $30 at BofA - TheFly
- 20 days ago - Amylyx announces $350M common stock offering - TheFly